Oruka Therapeutics ORKA
NASDAQ ORKA
$92.51 +1.52 (+1.67%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Change in Acquisitions & Divestments (2016 - 2026)

Oruka Therapeutics (ORKA) posted quarterly Change in Acquisitions & Divestments of $76.5 million for Q1 2026, down 12.27% year-over-year from $87.2 million in Q1 2025, and down 3.24% quarter-over-quarter from $79.0 million in Q4 2025.

Analysis

Oruka Therapeutics (ORKA) Change in Acquisitions & Divestments (2016 - 2026) Analysis & Trends

Oruka Therapeutics' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $76.5 million for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments fell 12.27% year-over-year to $76.5 million; the TTM figure through Mar 2026 stood at $413.7 million (up 374.62% YoY), while the FY2025 annual figure was $424.4 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $76.5 million, down from $79.0 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $145.3 million in Q3 2025, with the low at $76.5 million in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Oruka Therapeutics 5.85 Bn 4.12 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.60 Mn
Mar 31, 2026 76.47 Mn
Dec 31, 2025 79.03 Mn
Sep 30, 2025 145.33 Mn
Jun 30, 2025 112.89 Mn
Mar 31, 2025 87.17 Mn
Mar 31, 2018 3.05 Mn
Dec 31, 2017 4.75 Mn
Sep 30, 2017 2.50 Mn
Jun 30, 2017 6.60 Mn
Mar 31, 2017 4.55 Mn
Dec 31, 2016 3.15 Mn
Sep 30, 2016 500,000.00